How many insider trades does FilingIQ track for IBO?

FilingIQ tracks 39 Form 4 insider transactions for IBO (IMPACT BIOMEDICAL INC.), covering filings from Sep 16, 2024 onwards. 3 of those were filed in the last 90 days.

Are IBO insiders net buyers or net sellers?

Across the full Form 4 history for IBO, 8 transactions (21%) were open-market purchases and 31 (79%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does IBO insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is IBO in?

IMPACT BIOMEDICAL INC. (IBO) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $62.84M.

IBO insider trading

NYSE American Healthcare

IMPACT BIOMEDICAL INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

21% / 79%

Market cap

$62.84M

About IMPACT BIOMEDICAL INC.

Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. It also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, the company develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use as health supplements and medications. Further, it is developing 3F (functional fragrance formulation), a formulation of botanical ingredients. Impact BioMedical Inc. was incorporated in 2018 and is based in Houston, Texas. Impact BioMedical Inc. operates as a subsidiary of DSS BioHealth Security, Inc

Company website: www.impactbiomedinc.com

IBO insider activity at a glance

FilingIQ has scored 39 insider transactions for IBO since Sep 16, 2024. The most recent filing in our index is dated Mar 27, 2026.

Across the full history, 8 open-market purchases and 31 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on IBO insider trades is 62.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live IBO trades on FilingIQ Raw filings on SEC EDGAR

Latest IBO Form 4 filings

Macko Todd D Chief Financial Officer

Chan Heng Fai Ambrose

S Apr 3, 2025

Alset International Ltd

S Apr 1, 2025

DSS, INC.

S Mar 21, 2025

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for IBO?: FilingIQ tracks 39 Form 4 insider transactions for IBO (IMPACT BIOMEDICAL INC.), covering filings from Sep 16, 2024 onwards. 3 of those were filed in the last 90 days.
Are IBO insiders net buyers or net sellers?: Across the full Form 4 history for IBO, 8 transactions (21%) were open-market purchases and 31 (79%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does IBO insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is IBO in?: IMPACT BIOMEDICAL INC. (IBO) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $62.84M.

Methodology & sources

Every IBO insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.